Hikma Ventures

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide.

• We invest in disruptive technologies and meaningful companies, with a diverse leadership team, that can make a real difference in the world and for Hikma.
• Our investment mandate is quite broad, and we will invest in companies where we believe there is a true strategic advantage both for Hikma and our portfolio companies.
• Some of our main focus areas are: Drug Delivery, Digital Therapeutics, Clinical Trial Innovation, Respiratory, CNS, Oncology, and certain Autoimmune and Chronic Diseases such as Type II Diabetes and hypertension and areas that can help address overdose and abuse. 
• We aim to partner with our portfolio companies by leveraging HV and Hikma’s expertise and reach as a global generics pharmaceutical company, to drive their success.
• While we are investment stage-agnostic, we have a preference for Series A and beyond and we are happy to lead or co-lead
• We take a long-term perspective towards our portfolio companies.
• Our average investment ticket size is up to $5 million per company per round.